Meibomian Gland Density: An Effective Evaluation Index of Meibomian Gland Dysfunction Based on Deep Learning and Transfer Learning.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Deep-learning segmentation enabled a quantitative meibomian-gland density index, which the authors assessed against clinical meibomian-gland dysfunction status in 85 subjects. The reported AUC was 0.900 for total-eyelid density; the small diagnostic cohort and reuse of earlier training subjects limit independence.
Technology: Mask R-CNN segmented tarsus and ResNet50-U-Net with transfer learning segmented glands; 60 annotated training/validation subjects included 40 training images and 20 upper-lid validation images, while 85 subjects (53 MGD, 32 contro
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Mask R-CNN segmented tarsus and ResNet50-U-Net with transfer learning segmented glands; 60 annotated training/validation subjects included 40 training images and 20 upper-lid validation images, while 85 subjects (53 MGD, 32 controls) were used for clinical efficacy analysis. Density AUC 0.900 for total eyelids. Training overlap with prior report disclosed.
- Limitation / still unknown
- The diagnostic cohort included 85 subjects and reused earlier training subjects, limiting independence and generalization.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://mdpi-res.com/d_attachment/jcm/jcm-11-02396/article_deploy/jcm-11-02396.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.